| Primary |
| Product Used For Unknown Indication |
61.1% |
| Rheumatoid Arthritis |
5.2% |
| Diffuse Large B-cell Lymphoma |
3.1% |
| Prophylaxis |
2.8% |
| Systemic Lupus Erythematosus |
2.8% |
| Juvenile Idiopathic Arthritis |
2.5% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
2.5% |
| Affective Disorder |
1.9% |
| Asthma |
1.9% |
| Granulomatosis With Polyangiitis |
1.9% |
| Leprosy |
1.9% |
| B Precursor Type Acute Leukaemia |
1.5% |
| Diabetes Mellitus |
1.5% |
| Lower Respiratory Tract Infection |
1.5% |
| Lymphoma |
1.5% |
| Stem Cell Transplant |
1.5% |
| Anal Abscess |
1.2% |
| B-cell Lymphoma |
1.2% |
| Behcet's Syndrome |
1.2% |
| Dermatomyositis |
1.2% |
|
| Dyslipidaemia |
10.5% |
| Pulmonary Embolism |
7.9% |
| Pyrexia |
7.9% |
| Vomiting |
7.9% |
| Weight Increased |
7.9% |
| Dysglobulinaemia |
5.3% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Hyperglycaemia |
5.3% |
| Infection |
5.3% |
| Intraocular Pressure Increased |
5.3% |
| Mania |
5.3% |
| Pain In Extremity |
5.3% |
| Abscess |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Asthma |
2.6% |
| Bradycardia |
2.6% |
| Confusional State |
2.6% |
| Deep Vein Thrombosis |
2.6% |
| Diabetes Mellitus |
2.6% |
| Drug Ineffective |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
39.2% |
| Immunosuppression |
9.8% |
| Granulomatosis With Polyangiitis |
5.4% |
| Rheumatoid Arthritis |
4.7% |
| Lung Transplant |
4.4% |
| Immunosuppressant Drug Therapy |
4.1% |
| Diffuse Large B-cell Lymphoma |
3.7% |
| Peripheral T-cell Lymphoma Unspecified |
3.4% |
| Diffuse Large B-cell Lymphoma Stage Ii |
3.0% |
| Behcet's Syndrome |
2.7% |
| Pemphigus |
2.7% |
| Heart Transplant |
2.0% |
| Lupus Nephritis |
2.0% |
| Nasopharyngitis |
2.0% |
| Polymyalgia Rheumatica |
2.0% |
| Premedication |
2.0% |
| B-cell Lymphoma |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Liver Transplant |
1.7% |
| Temporal Arteritis |
1.7% |
|
| Obliterative Bronchiolitis |
26.0% |
| Tendon Rupture |
8.0% |
| Fall |
6.0% |
| Gastric Ulcer |
6.0% |
| Granulomatosis With Polyangiitis |
6.0% |
| Headache |
4.0% |
| Neutropenia |
4.0% |
| Pneumonia |
4.0% |
| Respiratory Tract Infection |
4.0% |
| Sinusitis Aspergillus |
4.0% |
| Tearfulness |
4.0% |
| Thrombocytopenia |
4.0% |
| Trismus |
4.0% |
| Urticaria |
4.0% |
| Abdominal Pain Upper |
2.0% |
| Acute Generalised Exanthematous Pustulosis |
2.0% |
| Anogenital Warts |
2.0% |
| Bronchopulmonary Aspergillosis |
2.0% |
| Coronary Artery Dissection |
2.0% |
| Cytomegalovirus Colitis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
62.5% |
| Depression |
12.5% |
| Hereditary Disorder |
12.5% |
| Pulmonary Arterial Hypertension |
12.5% |
|
| Angioedema |
16.7% |
| Hypersensitivity |
16.7% |
| Swelling Face |
16.7% |
| Thrombocytopenia |
16.7% |
| Vomiting |
16.7% |
| Wheezing |
16.7% |
|
| Interacting |
| Ewing's Sarcoma |
50.0% |
| Product Used For Unknown Indication |
37.5% |
| Oral Candidiasis |
12.5% |
|
| Paraesthesia |
50.0% |
| Urinary Tract Infection |
50.0% |
|
